627 top medical experts on Polycythemia Vera across 45 countries and 35 U.S. states, including 531 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Polycythemia Vera: A myeloproliferative disorder of unknown etiology, characterized by abnormal proliferation of all hematopoietic bone marrow elements and an absolute increase in red cell mass and total blood volume, associated frequently with splenomegaly, leukocytosis, and thrombocythemia. Hematopoiesis is also reactive in extramedullary sites (liver and spleen). In time myelofibrosis occurs.
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Bone Marrow Neoplasms (3,166), Myeloproliferative Disorders (3,110).
  4. Clinical Trials ClinicalTrials.gov : at least 185 including 16 Active, 91 Completed, 39 Recruiting
  5. Synonyms: Erythremia,  Osler-Vaquez Disease,  Polycythemia Rubra Vera


  

        

                    


    Computing Expert Listing ...

);